112 related articles for article (PubMed ID: 22261511)
1. Heterogeneity of microbubble accumulation: a novel approach to discriminate between well-differentiated hepatocellular carcinomas and regenerative nodules.
Maruyama H; Takahashi M; Sekimoto T; Kamesaki H; Shimada T; Kanai F; Yokosuka O
Ultrasound Med Biol; 2012 Mar; 38(3):383-8. PubMed ID: 22261511
[TBL] [Abstract][Full Text] [Related]
2. Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma.
Maruyama H; Takahashi M; Ishibashi H; Okabe S; Yoshikawa M; Yokosuka O
Eur J Radiol; 2010 Jul; 75(1):e102-6. PubMed ID: 19783392
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.
Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O
AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852
[TBL] [Abstract][Full Text] [Related]
4. Intensity-Based Assessment of Microbubble-Enhanced Ultrasonography: Phase-Related Diagnostic Ability for Cellular Differentiation of Hepatocellular Carcinoma.
Kondo T; Maruyama H; Kiyono S; Sekimoto T; Shimada T; Takahashi M; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Chiba T; Kanai F; Yokosuka O
Ultrasound Med Biol; 2015 Dec; 41(12):3079-87. PubMed ID: 26371403
[TBL] [Abstract][Full Text] [Related]
5. Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease.
Numata K; Fukuda H; Nihonmatsu H; Kondo M; Nozaki A; Chuma M; Morimoto M; Oshima T; Okada M; Murakami T; Takebayashi S; Maeda S; Inayama Y; Nakano M; Tanaka K
Abdom Imaging; 2015 Oct; 40(7):2372-83. PubMed ID: 26099473
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
[TBL] [Abstract][Full Text] [Related]
7. Liver Function Assessment Using Parenchyma-Specific Contrast-Enhanced Ultrasonography.
Park J; Cho J; Kwon H; Kang M; Lee S; Roh YH; Kim KW; Lee SW
Ultrasound Med Biol; 2016 Feb; 42(2):430-7. PubMed ID: 26610713
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma.
Arita J; Takahashi M; Hata S; Shindoh J; Beck Y; Sugawara Y; Hasegawa K; Kokudo N
Ann Surg; 2011 Dec; 254(6):992-9. PubMed ID: 21694582
[TBL] [Abstract][Full Text] [Related]
9. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
10. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
[TBL] [Abstract][Full Text] [Related]
12. How to characterize non-hypervascular hepatic nodules on contrast-enhanced computed tomography in chronic liver disease: feasibility of contrast-enhanced ultrasound with a microbubble contrast agent.
Yoshizumi H; Maruyama H; Okugawa H; Kobayashi S; Akiike T; Yoshikawa M; Ebara M; Yokosuka O; Matsutani S; Kondo F; Kamiyama N
J Gastroenterol Hepatol; 2008 Oct; 23(10):1528-34. PubMed ID: 17944882
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases.
Maruyama H; Takahashi M; Ishibashi H; Yoshikawa M; Yokosuka O
Br J Radiol; 2012 Apr; 85(1012):351-7. PubMed ID: 21224305
[TBL] [Abstract][Full Text] [Related]
14. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
15. CT diagnosis of early hepatocellular carcinoma: sensitivity, findings, and CT-pathologic correlation.
Takayasu K; Furukawa H; Wakao F; Muramatsu Y; Abe H; Terauchi T; Winter TC; Sakamoto M; Hirohashi S
AJR Am J Roentgenol; 1995 Apr; 164(4):885-90. PubMed ID: 7726041
[TBL] [Abstract][Full Text] [Related]
16. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio.
Wen YL; Kudo M; Zheng RQ; Ding H; Zhou P; Minami Y; Chung H; Kitano M; Kawasaki T; Maekawa K
AJR Am J Roentgenol; 2004 Apr; 182(4):1019-26. PubMed ID: 15039180
[TBL] [Abstract][Full Text] [Related]
17. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma.
Arita J; Hasegawa K; Takahashi M; Hata S; Shindoh J; Sugawara Y; Kokudo N
AJR Am J Roentgenol; 2011 Jun; 196(6):1314-21. PubMed ID: 21606294
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas--correlation with histological differentiation.
Strobel D; Kleinecke C; Hänsler J; Frieser M; Händl T; Hahn EG; Bernatik T
Ultraschall Med; 2005 Aug; 26(4):270-6. PubMed ID: 16123920
[TBL] [Abstract][Full Text] [Related]
19. Focal hepatic lesions: contrast-enhancement patterns at pulse-inversion harmonic US using a microbubble contrast agent.
Kim EA; Yoon KH; Lee YH; Kim HW; Juhng SK; Won JJ
Korean J Radiol; 2003; 4(4):224-33. PubMed ID: 14726639
[TBL] [Abstract][Full Text] [Related]
20. Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging.
Takahashi M; Maruyama H; Shimada T; Kamezaki H; Sekimoto T; Kanai F; Yokosuka O
Eur J Radiol; 2013 Jan; 82(1):75-84. PubMed ID: 23116806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]